Monday Morning's Movers: LGF, MSFT, SRE >>> READ MORE

TEVA

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Gain 30%

Teva (TEVA) has been unfairly beat down, but its near-5% dividend yield makes TEVA stock worthwhile while waiting on the recovery. More 

3 Naked Puts for $1,000 in Summertime Cash

Use these three naked put options to generate $1,000-plus in cash, or lower the effective purchase price of a stock. More 

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Going to $40

Teva Pharmaceutical (TEVA) offers good value, especially when combined with its 4.49% annual dividend yield. Here's how TEVA stock is heading to $40. More 

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Recover

TEVA stock has been slammed with poor news and fierce competition, but with a little luck, Teva Pharmaceuticals could be a big play in 2017. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now

Teva Pharmaceutical's first-quarter earnings and reaffirmed guidance are good enough, and should at least drive a relief rally in TEVA stock. More 

Should You Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock? 3 Pros, 3 Cons

TEVA stock has had a terrible year. While the situation is still fraught with risk, however, the upside is starting to look compelling. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance

Teva Pharmaceuticals (TEVA) has been on a downward spiral for the past year, but much of the bad news may already be baked into TEVA stock. More